» Articles » PMID: 37511907

Discovering Deleterious Single Nucleotide Polymorphisms of Human AKT1 Oncogene: An In Silico Study

Overview
Journal Life (Basel)
Specialty Biology
Date 2023 Jul 29
PMID 37511907
Authors
Affiliations
Soon will be listed here.
Abstract

Background: AKT1 is a serine/threonine kinase necessary for the mediation of apoptosis, angiogenesis, metabolism, and cell proliferation in both normal and cancerous cells. The mutations in the AKT1 gene have been associated with different types of cancer. Further, the AKT1 gene mutations are also reported to be associated with other diseases such as Proteus syndrome and Cowden syndromes. Hence, this study aims to identify the deleterious AKT1 missense SNPs and predict their effect on the function and structure of the AKT1 protein using various computational tools.

Methods: Extensive in silico approaches were applied to identify deleterious SNPs of the human AKT1 gene and assessment of their impact on the function and structure of the AKT1 protein. The association of these highly deleterious missense SNPs with different forms of cancers was also analyzed. The in silico approach can help in reducing the cost and time required to identify SNPs associated with diseases.

Results: In this study, 12 highly deleterious SNPs were identified which could affect the structure and function of the AKT1 protein. Out of the 12, four SNPs-namely, G157R, G159V, G336D, and H265Y-were predicted to be located at highly conserved residues. G157R could affect the ligand binding to the AKT1 protein. Another highly deleterious SNP, R273Q, was predicted to be associated with liver cancer.

Conclusions: This study can be useful for pharmacogenomics, molecular diagnosis of diseases, and developing inhibitors of the AKT1 oncogene.

Citing Articles

Exploring the impact of deleterious missense nonsynonymous single nucleotide polymorphisms in the DRD4 gene using computational approaches.

Sarker D, Ray P, Salam F, Uddin S Sci Rep. 2025; 15(1):3150.

PMID: 39856236 PMC: 11761060. DOI: 10.1038/s41598-025-86916-w.


Exploring the Structural and Functional Consequences of Deleterious Missense Nonsynonymous SNPs in the Gene: A Computational Approach.

Ali E, Adam K, Elangeeb M, Ahmed E, Abuagla H, MohamedAhmed A J Pers Med. 2024; 14(11).

PMID: 39590603 PMC: 11595312. DOI: 10.3390/jpm14111111.


Network pharmacology prediction and experiment validation of anti-liver cancer activity of Curcumae Rhizoma and Hedyotis diffusa Willd.

Tie S, Tong T, Zhan G, Li X, Ouyang D, Cao J Ann Med Surg (Lond). 2024; 86(6):3337-3348.

PMID: 38846818 PMC: 11152801. DOI: 10.1097/MS9.0000000000002074.

References
1.
Liu P, Cheng H, Roberts T, Zhao J . Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov. 2009; 8(8):627-44. PMC: 3142564. DOI: 10.1038/nrd2926. View

2.
Rahaman M, Islam R, Nurnabi Azad Jewel G, Hoque H . Implementation of computational approaches to explore the deleterious effects of non-synonymous SNPs on pRB protein. J Biomol Struct Dyn. 2021; 40(16):7256-7273. DOI: 10.1080/07391102.2021.1896385. View

3.
Savojardo C, Manfredi M, Martelli P, Casadio R . Solvent Accessibility of Residues Undergoing Pathogenic Variations in Humans: From Protein Structures to Protein Sequences. Front Mol Biosci. 2021; 7:626363. PMC: 7817970. DOI: 10.3389/fmolb.2020.626363. View

4.
Do H, Solomon B, Mitchell P, Fox S, Dobrovic A . Detection of the transforming AKT1 mutation E17K in non-small cell lung cancer by high resolution melting. BMC Res Notes. 2008; 1:14. PMC: 2442881. DOI: 10.1186/1756-0500-1-14. View

5.
Khan I, Ansari I . Prediction of a highly deleterious mutation E17K in AKT-1 gene: An approach. Biochem Biophys Rep. 2017; 10:260-266. PMC: 5637233. DOI: 10.1016/j.bbrep.2017.04.013. View